Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05064306
Title 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Age Groups: child | adult | senior
Covered Countries USA

No variant requirements are available.